Institutional Relations
Records, legal processes, good manufacturing practices, and updating standards to ensure efficiency and compliance with Brazilian legislation.
Technical and Regulatory Support
We create connections between Indian pharmaceutical industries and the Brazilian market, supporting negotiations, events, trade missions, and strategic collaborations.
Partnerships & Business
We act as a bridge between Indian companies and Brazilian authorities such as Anvisa, the Ministry of Health, and other strategic entities.
Who we are
Representation that strengthens
the Indian pharmaceutical
industry in Brazil.
ABRIFI – the Brazilian Association of the Indian Pharmaceutical Industry – is an organization that represents Indian pharmaceutical companies operating in Brazil. Our role is to promote institutional dialogue, strengthen strategic partnerships, and ensure regulatory compliance with Brazilian agencies. We act as a bridge between two giants of the global industry: India and Brazil.
Strengthened bonds.
Promoted health.
In addition to active participation
in trade fairs, congresses, and
bilateral meetings, we promote
Institutional Relations
Dialogue with Anvisa (Brazilian Health Regulatory Agency), the Ministry of Health, and other entities.
Compliance and Regulation
Support for members to ensure legal and health compliance.
Trade Promotion
Promoting business between Indian and Brazilian companies.
The Indian industry
A global powerhouse in affordable,
quality medicines.
India is recognized worldwide as the “pharmacy of the world”—occupying a prominent position among the largest producers of generic medicines and pharmaceutical ingredients (APIs). With a robust research, development, and production ecosystem, the country supplies more than 200 markets and is a benchmark for innovation at an affordable cost.
The Brazilian industry
A growing market with high demand
for innovation and global partnerships.
Brazil has one of the largest pharmaceutical markets in the world, with a complex and constantly growing healthcare system. The demand for quality medicines, biotechnology, innovation, and affordable prices creates opportunities for strategic partnerships that drive the sector’s development.
The force of ABRIFI
We strengthen the bridge between Brazil
and India, promoting innovation, access,
and safety in the pharmaceutical sector. ABRIFI represents trust, technological advancement,
and a commitment to health.
Established International Presence
We connect Brazil to the strength of the Indian pharmaceutical industry — one of the world’s largest producers of generic drugs, raw materials, and innovative solutions.
Strategic Partnerships
We facilitate dialogue between companies, regulators, and healthcare professionals to build lasting and sustainable partnerships in the Brazilian market.
Commitment to Quality
We promote high-quality medicines at affordable prices, helping to expand access to healthcare in Brazil based on science, safety, and proper regulation.
Who does
Cristianne Gonçalves
President
LAWYER SPECIALIZING IN GOVERNMENT AND INSTITUTIONAL RELATIONS FROM MACKENZIE PRESBYTERIAN UNIVERSITY. PHARMACEUTICAL-BIOCHEMIST WITH A SPECIALIZATION IN HEALTH SURVEILLANCE IN PUBLIC HEALTH FROM THE SCHOOL OF PUBLIC HEALTH, UNIVERSITY OF SÃO PAULO – USP, WITH A REMARKABLE CAREER AT ANVISA, WHERE SHE SERVED AS DEPUTY DIRECTOR, ADVISOR TO THE PRESIDENT, AND COORDINATOR OF THE BRAZILIAN PHARMACOPOEIA, SHE ALSO WORKED IN HEALTH INSPECTION AND OMBUDSMAN, IN ADDITION TO BEING A COUNSELOR OF THE REGIONAL COUNCIL OF PHARMACY OF THE STATE OF SÃO PAULO (CRF/SP) AND A MEMBER OF THE REGULATORY AFFAIRS AND INNOVATION COMMITTEES OF THE BRAZILIAN BAR ASSOCIATION OF THE FEDERAL DISTRICT (OAB/DF).
Digvijay Singh
vice president
Physician with extensive executive experience in the pharmaceutical industry, having held the positions of CEO for Latin America at Sun Pharma and Ranbaxy, with strong experience in strategic leadership and market expansion in the region.
Glauco Santos
Legal and Regulatory Director
Lawyer and CEO of Glauco Santos Advogados Associados, with a solid background in Regulatory and Constitutional Law. A doctoral candidate at the University of Buenos Aires and with a master’s degree from IDP, he possesses extensive institutional experience, having worked at the Brazilian Bar Association (OAB), the National Electric Energy Agency (ANEEL), the Energy Company of Brasília (CEB), and holding a strategic position at BRB, in addition to significant involvement in national regulatory processes.
Let’s build the future of healthcare together?
ABRIFI connects innovation, partnerships, and access in the pharmaceutical sector between Brazil and India. If you represent a company, regulatory body, or institution interested in opportunities with the Indian industry, please contact us.
Partners
News and Publications
Why a trusted legal partner is essential for pharmaceutical companies entering the Brazilian market
Legal certainty, regulatory efficiency, and risk mitigation in one[…]
The importance of having a strong legal partner when commercializing pharmaceutical products in Brazil
Navigating regulatory complexity, legal obligations, and timelines with security[…]
A relevância do mercado brasileiro para as fabricantes farmacêuticas
Por que o Brasil é estratégico para a expansão[…]
Contact ABRIFI
Do you have questions, suggestions, or would you like to know more about partnerships with the Indian pharmaceutical industry in Brazil? Our team is ready to listen to you. Contact ABRIFI.